Transposagen Biophamaceuticals is Biotechnology in United States that focus on drug discovery business. Founded in 2003. They cover business area such as developer, animal model, cell line, stem cell, research tool, technology, drug discovery and development research, genetically modify rat model, academic laboratory, Health.
2003
( 21 years old in 2024 )
Drug Discovery
-
535 West Second Street
Suite L102
Lexington, KY 40508
United States
Private
developeranimal modelcell linestem cellresearch tooltechnologydrug discovery and development researchgenetically modify rat modelacademic laboratoryHealth
* We use standard office opening hours in near Transposagen Biophamaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Transposagen Biophamaceuticals is Biotechnology business from United States that founded in 2003 (21 years old in 2024), Transposagen Biophamaceuticals business is focusing on Drug Discovery.
Transposagen Biophamaceuticals headquarter office and corporate office address is located in 535 West Second Street Suite L102 Lexington, KY 40508 United States.
Transposagen Biophamaceuticals was founded in United States.
In 2024, Transposagen Biophamaceuticals is currently focus on drug discovery sector.
Above is snippet of Google Trends for "drug discovery" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Transposagen Biophamaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
